{"pmid":32460632,"title":"Viral Infections in Burns.","text":["Viral Infections in Burns.","Background: Viral infections after burns are less common than bacterial infections but usually occur in the more severely burned patients and have been associated with poor outcomes. Methods: Retrospective reviews and case series were examined to provide an overview of the management of viral infections in the burn patient. Results: The most common viral pathogens in these patients are the herpesviruses, which include herpes simplex, varicella zoster, cytomegalovirus, and human herpesvirus 6. Established viral infections that may complicate patient management include human immunodeficiency virus, hepatitis B and C, and, more recently, the novel coronavirus SARS-CoV-2. Herpesvirus infections can occur as primary or nosocomial pathogens but clinical manifestations most commonly are re-activation of latent viral infection. Because of the paucity of data in the burn population, much of the evidence for specific treatments is extrapolated from patients with severe immunosuppression or critical illness. Antiviral therapy is employed for the burn patient with herpesvirus infections. This is an area of active study, and further research is needed to better understand the risks, clinical manifestations, and attributable morbidity and mortality of viral infections. Conclusions: Major burn injury results in immunosuppression and viral infection in a small number of patients. Recognition and antiviral therapy are employed, but additional studies are necessary to improve outcomes in these patients.","Surg Infect (Larchmt)","Kiley, John L","Chung, Kevin K","Blyth, Dana M","32460632"],"abstract":["Background: Viral infections after burns are less common than bacterial infections but usually occur in the more severely burned patients and have been associated with poor outcomes. Methods: Retrospective reviews and case series were examined to provide an overview of the management of viral infections in the burn patient. Results: The most common viral pathogens in these patients are the herpesviruses, which include herpes simplex, varicella zoster, cytomegalovirus, and human herpesvirus 6. Established viral infections that may complicate patient management include human immunodeficiency virus, hepatitis B and C, and, more recently, the novel coronavirus SARS-CoV-2. Herpesvirus infections can occur as primary or nosocomial pathogens but clinical manifestations most commonly are re-activation of latent viral infection. Because of the paucity of data in the burn population, much of the evidence for specific treatments is extrapolated from patients with severe immunosuppression or critical illness. Antiviral therapy is employed for the burn patient with herpesvirus infections. This is an area of active study, and further research is needed to better understand the risks, clinical manifestations, and attributable morbidity and mortality of viral infections. Conclusions: Major burn injury results in immunosuppression and viral infection in a small number of patients. Recognition and antiviral therapy are employed, but additional studies are necessary to improve outcomes in these patients."],"journal":"Surg Infect (Larchmt)","authors":["Kiley, John L","Chung, Kevin K","Blyth, Dana M"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32460632","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1089/sur.2020.130","keywords":["sarts-co-v-2 virus","antiviral drugs","burns","cytomegalovirus","herpes simplex virus","human immunodeficiency virus","varicella zoster virus"],"locations":["Herpesvirus","herpesvirus","Burns"],"topics":["Mechanism","Treatment"],"weight":1,"_version_":1668079521541128192,"score":9.490897,"similar":[{"pmid":32077677,"title":"[Management strategy of Novel coronavirus pneumonia in burn and wound care ward].","text":["[Management strategy of Novel coronavirus pneumonia in burn and wound care ward].","The prevention and control of novel coronavirus pneumonia (NCP) has already entered a key period . The patients treated in the burn and wound care ward are susceptible to viral infection because of disease, age and other factors, so it is very important to manage the burn and wound care ward during the prevention and control of NCP epidemic. In this paper, combining with the key clinical problems of prevention and control in hospital during the epidemic period of NCP infection, medical evidence, and clinical and management experience, the author formulates prevention and control management strategy of the author's unit in order to provide reference for prevention and control of burn and wound care ward.","Zhonghua Shao Shang Za Zhi","Li, N","Liu, T M","Chen, H L","Liao, J M","32077677"],"abstract":["The prevention and control of novel coronavirus pneumonia (NCP) has already entered a key period . The patients treated in the burn and wound care ward are susceptible to viral infection because of disease, age and other factors, so it is very important to manage the burn and wound care ward during the prevention and control of NCP epidemic. In this paper, combining with the key clinical problems of prevention and control in hospital during the epidemic period of NCP infection, medical evidence, and clinical and management experience, the author formulates prevention and control management strategy of the author's unit in order to provide reference for prevention and control of burn and wound care ward."],"journal":"Zhonghua Shao Shang Za Zhi","authors":["Li, N","Liu, T M","Chen, H L","Liao, J M"],"date":"2020-02-21T11:00:00Z","year":2020,"_id":"32077677","source":"PubMed","week":"20208|Feb 17 - Feb 23","doi":"10.3760/cma.j.cn501120-20200210-00050","keywords":["burns","epidemic prevention and control","novel coronavirus pneumonia","patients' rooms"],"topics":["Prevention"],"weight":1,"_version_":1666138492955000832,"score":288.0687},{"pmid":32340120,"title":"Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19.","text":["Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19.","The whole world is currently facing an unseen enemy, called coronavirus disease 2019 (COVID-19), which is causing a global pandemic. This disease is caused by a novel single-stranded enveloped RNA virus, known as the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Although huge efforts are being made to produce effective therapies to combat this disease, it continues to be one of the greatest challenges in medicine. There is no doubt that herpesviruses are one of the most important viruses that infect humans and animals, and infections induced by these pathogens have developed into a great threat to public health. According to the currently available evidence, the correlation between herpesviruses and coronaviruses is limited to the induced complications following the infections. For instance, the inflammation that is induced at the sites of infection could tie these viruses to each other in a relationship. Another example, bovine herpesvirus 1, which is an important pathogen of cattle, can cause a severe respiratory infection; the same way in which SARS-CoV-2 affects humans. Considering the current circumstances related to the COVID-19 crisis, this editorial paper, which belongs to the Special Issue \"Recent Advances in Herpesviruses Research: What's in the Pipeline?\" aims to draw attention to some natural anti-herpesvirus alkaloid compounds, which have recently been proven to have excellent inhibitory efficacy against SARS-CoV-2 replication. Thus, this special focus is an attempt to hunt down various treatment options to combat COVID-19 based on repurposing drugs that are known to have multiple antiviral properties, including against herpesvirus.","Viruses","Hassan, Sherif T S","32340120"],"abstract":["The whole world is currently facing an unseen enemy, called coronavirus disease 2019 (COVID-19), which is causing a global pandemic. This disease is caused by a novel single-stranded enveloped RNA virus, known as the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). Although huge efforts are being made to produce effective therapies to combat this disease, it continues to be one of the greatest challenges in medicine. There is no doubt that herpesviruses are one of the most important viruses that infect humans and animals, and infections induced by these pathogens have developed into a great threat to public health. According to the currently available evidence, the correlation between herpesviruses and coronaviruses is limited to the induced complications following the infections. For instance, the inflammation that is induced at the sites of infection could tie these viruses to each other in a relationship. Another example, bovine herpesvirus 1, which is an important pathogen of cattle, can cause a severe respiratory infection; the same way in which SARS-CoV-2 affects humans. Considering the current circumstances related to the COVID-19 crisis, this editorial paper, which belongs to the Special Issue \"Recent Advances in Herpesviruses Research: What's in the Pipeline?\" aims to draw attention to some natural anti-herpesvirus alkaloid compounds, which have recently been proven to have excellent inhibitory efficacy against SARS-CoV-2 replication. Thus, this special focus is an attempt to hunt down various treatment options to combat COVID-19 based on repurposing drugs that are known to have multiple antiviral properties, including against herpesvirus."],"journal":"Viruses","authors":["Hassan, Sherif T S"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340120","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.3390/v12040476","keywords":["covid-19","sars-cov-2","alkaloids","anti-herpesvirus drugs","herpesviruses"],"topics":["Treatment"],"weight":1,"_version_":1666138495788253184,"score":282.85104},{"pmid":32353825,"pmcid":"PMC7177133","title":"Occupational exposure to SARS-CoV-2 in burns treatment during the COVID-19 epidemic: Specific diagnosis and treatment protocol.","text":["Occupational exposure to SARS-CoV-2 in burns treatment during the COVID-19 epidemic: Specific diagnosis and treatment protocol.","Epidemic prevention and control measures for the new coronavirus disease 2019 (COVID-19) has achieved significant results. As of 8 April 2020, 22,073 infection cases of COVID-19 among healthcare workers from 52 countries had been reported to WHO. COVID-19 has strong infectivity, high transmission speeds, and causes serious infection among healthcare worker. Burns are an acute-care condition, and burn treatment needs to be initiated before COVID-19 infection status can be excluded. The key step to infection prevention is to identify risk points of infection exposure, strengthen the protection against those risk points, and formulate an appropriate diagnosis and treatment protocol. Following an in-depth study of the latest literature on COVID-19 diagnosis and treatment, we reviewed the protocols surrounding hospitalization of patients with extensive burns (area>/=50 %) in our hospital from February 2009 to February 2019 and, in accordance with the epidemiological characteristics of COVID-19, developed an algorithm for protection during diagnosis and treatment of burns. Therefore, the aspects of medical protection and the diagnosis and treatment of burns appear to be particularly important during the prevention and control of the COVID-19. This algorithm was followed for 4 patients who received emergency treatment in February 2020 and were hospitalized. All healthcare worker were protected according to the three-tiered protective measures, and there was no nosocomial infection. During the COVID-19 epidemic, the early stages of emergency treatment for patients with extensive burns requiring the establishment of venous access for rehydration, endotracheal intubation or tracheostomy, wound treatment, and surgery are the risk points for exposure to infection. The implementation of effective, appropriate-grade protection and formulation of practical treatment protocols can increase protection of healthcare worke and reduce the risk of COVID-19 infection exposure.","Biomed Pharmacother","Huang, Zhifeng","Zhuang, Donglin","Xiong, Bing","Deng, David Xingfei","Li, Hanhua","Lai, Wen","32353825"],"abstract":["Epidemic prevention and control measures for the new coronavirus disease 2019 (COVID-19) has achieved significant results. As of 8 April 2020, 22,073 infection cases of COVID-19 among healthcare workers from 52 countries had been reported to WHO. COVID-19 has strong infectivity, high transmission speeds, and causes serious infection among healthcare worker. Burns are an acute-care condition, and burn treatment needs to be initiated before COVID-19 infection status can be excluded. The key step to infection prevention is to identify risk points of infection exposure, strengthen the protection against those risk points, and formulate an appropriate diagnosis and treatment protocol. Following an in-depth study of the latest literature on COVID-19 diagnosis and treatment, we reviewed the protocols surrounding hospitalization of patients with extensive burns (area>/=50 %) in our hospital from February 2009 to February 2019 and, in accordance with the epidemiological characteristics of COVID-19, developed an algorithm for protection during diagnosis and treatment of burns. Therefore, the aspects of medical protection and the diagnosis and treatment of burns appear to be particularly important during the prevention and control of the COVID-19. This algorithm was followed for 4 patients who received emergency treatment in February 2020 and were hospitalized. All healthcare worker were protected according to the three-tiered protective measures, and there was no nosocomial infection. During the COVID-19 epidemic, the early stages of emergency treatment for patients with extensive burns requiring the establishment of venous access for rehydration, endotracheal intubation or tracheostomy, wound treatment, and surgery are the risk points for exposure to infection. The implementation of effective, appropriate-grade protection and formulation of practical treatment protocols can increase protection of healthcare worke and reduce the risk of COVID-19 infection exposure."],"journal":"Biomed Pharmacother","authors":["Huang, Zhifeng","Zhuang, Donglin","Xiong, Bing","Deng, David Xingfei","Li, Hanhua","Lai, Wen"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32353825","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1016/j.biopha.2020.110176","keywords":["burns","covid-19","epidemic prevention and control","exposure risk","healthcare-associated infections","protection"],"topics":["Prevention"],"weight":1,"_version_":1666138495592169472,"score":282.53967},{"pmid":32473015,"title":"Managing burns during COVID-19 outbreak.","text":["Managing burns during COVID-19 outbreak.","The coronavirus disease pandemic has affected our practice as healthcare professionals (HCP). As burn surgeons, we are obliged to provide the best possible care to our patients. However, due to the risk of viral transmission, the goal should be to provide safe care to our patients as well as ensure the safety of the whole team providing burn care. The burn patients are usually debilitated and require a prolonged hospital stay and multiple operative procedures which puts them and everyone involved in their care at increased risk of coronavirus infections and transmission. This warrants special caution to the burn team while managing such patients. In this review, we aim to highlight the key considerations for burn care teams while dealing with burn patients during the COVID-19 pandemic.","J Burn Care Res","Saha, Shivangi","Kumar, Aditya","Dash, Suvashis","Singhal, Maneesh","32473015"],"abstract":["The coronavirus disease pandemic has affected our practice as healthcare professionals (HCP). As burn surgeons, we are obliged to provide the best possible care to our patients. However, due to the risk of viral transmission, the goal should be to provide safe care to our patients as well as ensure the safety of the whole team providing burn care. The burn patients are usually debilitated and require a prolonged hospital stay and multiple operative procedures which puts them and everyone involved in their care at increased risk of coronavirus infections and transmission. This warrants special caution to the burn team while managing such patients. In this review, we aim to highlight the key considerations for burn care teams while dealing with burn patients during the COVID-19 pandemic."],"journal":"J Burn Care Res","authors":["Saha, Shivangi","Kumar, Aditya","Dash, Suvashis","Singhal, Maneesh"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473015","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1093/jbcr/iraa086","topics":["Prevention"],"weight":1,"_version_":1668255193334022144,"score":281.56888},{"pmid":32381449,"title":"Management strategies for the burn ward during COVID-19 pandemic.","text":["Management strategies for the burn ward during COVID-19 pandemic.","COVID-19 pandemic is sweeping the globe. Any outpatient or new inpatient especial in burn department during the pandemic should be as a potential infectious source of COVID-19. It is very important to manage the patients and wards carefully and correctly to prevent epidemic of the virus in burn centers. This paper provides some strategies regarding management of burn ward during the epidemic of COVID-19 or other respiratory infectious diseases.","Burns","Li, Ning","Liu, Tingmin","Chen, Hualing","Liao, Jianmei","Li, Haisheng","Luo, Qizhi","Song, Huapei","Xiang, Fei","Tan, Jianglin","Zhou, Junyi","Hu, Gaozhong","Yuan, Zhiqiang","Peng, Yizhi","Luo, Gaoxing","32381449"],"abstract":["COVID-19 pandemic is sweeping the globe. Any outpatient or new inpatient especial in burn department during the pandemic should be as a potential infectious source of COVID-19. It is very important to manage the patients and wards carefully and correctly to prevent epidemic of the virus in burn centers. This paper provides some strategies regarding management of burn ward during the epidemic of COVID-19 or other respiratory infectious diseases."],"journal":"Burns","authors":["Li, Ning","Liu, Tingmin","Chen, Hualing","Liao, Jianmei","Li, Haisheng","Luo, Qizhi","Song, Huapei","Xiang, Fei","Tan, Jianglin","Zhou, Junyi","Hu, Gaozhong","Yuan, Zhiqiang","Peng, Yizhi","Luo, Gaoxing"],"date":"2020-05-09T11:00:00Z","year":2020,"_id":"32381449","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.burns.2020.03.013","keywords":["burns","covid-19","managing strategies","ward"],"topics":["Prevention"],"weight":1,"_version_":1666267276778668032,"score":268.6366}]}